A novel, safe and sensitive method of Spectrophotometric estimation in UV -region has been developed for the assay of Fimasartan in its tablet formulation. The present study was undertaken to develop and validate a simple, accurate, precise, reproducible and cost effective UV spectrophotometric method for the estimation of Fimasartan bulk and pharmaceutical formulation. The method have been developed and validated for the assay of Fimasartan using Methanol as diluent. Absorption maximum (λmax) of the drug was found to be 240nm. The quantitative determination of the drug was carried out at 240nm. The method was shown linear in the mentioned concentrations having correlation coefficient R 2 of 0.999. The recovery values for Fimasartan ranged from 98.74% to 99.23%.The Percent Relative Standard Deviation of interday and intraday was 0.85% and 0.75% respectively. All the parameters of the analysis were chosen according to the International Conference on Harmonisation guideline and validated statistically using Relative Standard Deviation and Percent Relative Standard Deviation. Hence, proposed method was precise, accurate and cost effective. This method could be applicable for quantitative determination of the bulk drug as well as dosage formulation.
INTRODUCTION

Spectroscopy Methods
t is the branch of science dealing with the study of interaction between Electromagnetic radiation and matter. It is a most powerful tool available for the study of atomic and molecular structure/s and is used in the analysis of wide range of samples. Optical spectroscopy includes the region on electromagnetic spectrum between 100 Å and 400 μm. 1, 2 The regions of electromagnetic spectrum are shown in Table No. 1.
UV Spectrophotometry
UV spectrophotometry is one of the most frequently employed techniques in pharmaceutical analysis. It involves measuring the amount of ultraviolet or visible radiation absorbed by a substance in solution. Instrument which measure the ratio, or function of ratio, of the intensity of two beams of light in the UV region are called UV spectrophotometers. In qualitative analysis, organic compounds can be identified by use of spectrophotometer, if any recorded data is available, and quantitative spectrophotometric analysis is used to ascertain the quantity of molecular species absorbing the radiation. Spectrophotometric technique is simple, rapid, moderately specific and applicable to small quantities of compounds. The fundamental law that governs the quantitative spectrophotometric analysis is the Beer -Lambert law. 3 Beer's law: It states that the intensity of a beam of parallel monochromatic radiation decreases exponentially with the I ISSN: 2320-4850
[27] CODEN (USA): AJPRHS number of absorbing molecules. In other words, absorbance is proportional to the concentration. Lambert's law: It states that the intensity of a beam of parallel monochromatic radiation decreases exponentially as it passes through a medium of homogeneous thickness. A combination of these two laws yields the Beer-Lambert law. Beer-Lambert law: When beam of light is passed through a transparent cell containing a solution of an absorbing substance, reduction of the intensity of light may occur. Mathematically, Beer-Lambert law is expressed as A=a b c Where, A=absorbance or optical density a=absorptivity or extinction coefficient b=path length of radiation through sample (cm) c=concentration of solute in solution.
Both b and a are constant so a is directly proportional to the concentration c When c is in gm/100 ml, then the constant is called A (1%, 1 cm) A = A (1% /1cm) bc Quantification of medicinal substance using spectrophotometer may carried out by preparing solution in transparent solvent and measuring it's absorbance at suitable wavelength. The wavelength normally selected is wavelength of maximum absorption (λmax), where small error in setting the wavelength scale has little effect on measured absorbance. 
INTRODUCTION TO FIMASARTAN
Fimasartan is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure. Through oral administration, fimasartan blocks angiotensin II receptor type 1 (AT 1 receptors), reducing prohypertensive actions of angiotensin II, such as systemic vasoconstriction and water retention by the kidneys. Concurrent administration of fimasartan with diuretic hydrochlorothiazide has shown to be safe in clinical trials. Fimasartan is being marketed in India under the brand name of Fimanta and Fimagen through Ajanta Pharma Ltd. 4, 5 Description IUPAC name: 2-n-butyl-5-dimethylaminothiocarbonylmethyl -6-methyl-3, pyrimidin-4(3H). (Fig. 1 ) Fimasartan is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure. Concurrent administration of fimasartan with diuretic hydrochlorothiazide has shown to be safe in clinical trials. Through oral administration, fimasartan blocks angiotensin II receptor type 1 (AT 1 receptors), reducing prohypertensive actions of angiotensin II, such as systemic vasoconstriction and water retention by the kidneys. 14, 15, 16 
Mechanism of action
Fimasartan acts on the kidney's rennin-angiotensin cascade, which begins when renin release from the kidney causes the breakdown of angiotensinogen into angiotensin I. Angiotensin-converting enzyme (ACE) then catalyzes the reaction that forms angiotensin II, which acts on AT 1 receptors on the blood vessels, heart, and kidneys. On blood vessels, the AT 1 receptor is coupled to an intracellular pathway that causes vasoconstriction of blood vessels. In blocking the AT 1 receptor, fimasartan inhibits vasoconstriction, favouring vasodilation. ARBs like fimasartan have also shown to be protective against stroke, myocardial infarction, and heart failure.
Pharmacology
Fimasartan is rapidly absorbed and has minimal accumulation in the body 7 days after administration. Fimasartan possesses a half-life of 9 to 16 hours, appropriate for daily dosing. Fimasartan was found to be effective in fasted or fed states, with a variety of dosing regimens. Fimasartan was found mostly in unmetabolized form in the plasma and in bile excretions. Urinary elimination of the drug was low, at less than 3% 24 hours after administration, entailing that the fimasartan does not undergo renal excretion. 15, 16 
METHOD VALIDATION
Validation is concerned with assuring that a measurement process produces valid measurements. Results from method validation can be used to judge the quality, reliability and consistency of analytical results. It is an integral part of any good analytical practice. A measurement process producing valid measurements for an intended application is fit for purpose. Analytical methods need to be validated or revalidated, before their introduction into routine use; whenever the conditions change for which the method has been validated. The analytical procedure refers to the way of performing the analysis. It should describe in detail the steps necessary to perform each analytical test. This may include but is not limited to: the sample, the reference standard and the reagents preparations, use of the apparatus, generation of the calibration curve, use of the formula for the calculation. 17,19
ICH guidelines (ICH Q2R1) for analytical procedure and validation
Types of analytical procedures to be validated
The objective of the analytical procedure should be clearly understood since this will govern the validation characteristics which need to be evaluated.
AIM OF PRESENT WORK
This work deals with the validation of the developed method for the assay of Fimasartan from its dosage form (tablets). Hence, the method can be used for routine quality control analysis and also stability. The aim and scope of the proposed work are as under:
• To develop suitable spectrophotometric method for assay of Fimasartan tablet.
• Perform the validation for the method.
EXPERIMENTAL Materials
Fimasartan standard was provided by Ajanta Pharma Pvt. Ltd. (India). Fimagen tablets containing 60 mg Fimasartan was obtained from market. Analytical grade methanol obtained from Spectrochem Pvt. Ltd., Mumbai (India).
Diluent Preparation
Methanol used as a diluent.
Standard Preparation
1 mg drug was dissolved in 10 ml methanol and was shaken well. Then methanol was added to it to adjust the volume up to 100 ml. From that, dilutions of concentration 2, 4, 6, 8, 10, 12, 14, 16, 18, 20 µg/ml was prepared by using diluent.
Test Preparation
Weigh 20 tablets and powdered. Powdered tablet equivalent to 60 mg of Fimasartan was weighed and taken into 100 ml volumetric flask then 50 ml of methanol was added and shaken well to dissolve it after that methanol was added to adjust the volume up to 100 ml. From this solution required dilutions are prepared.
Instrumentation
UV-Visible double beam spectrophotometer with matched quartz cells. Model: UV -1800 (Shimadzu)
Selection of Wavelength
Scan standard solution in UV spectrophotometer between 200 nm to 400 nm on spectrum mode, using diluents as a blank. Fimasartan shows λmax at 240. (Fig. 2)   Figure 2 : Graph of UV λmax
METHOD VALIDATION Linearity:
Fresh aliquots were prepared from standard stock solution ranging from 2-20 μg/ml and the absorbance values of each was recorded at 240 nm for this method using Methanol as blank. The response was found to be linear in the investigation concentration range. (Table No. 2, Fig. 3 ). Precision: In intraday study, concentration of replicates of drug was calculated on the same day for three times. In inter-day study the concentration of drug were calculated on three successive days which expresses the laboratory variation in different days. In both intra and inter day precision study for the methods %RSD was calculated. (Table No. 3).
Accuracy: Accuracy of the developed method was confirmed by performing recovery studies at three different concentration ranges 80%, 100%, 120% each one in triplicate. From the recovery studies it was clear that the method is very accurate for quantitative estimation of tablet as the statistical results were within the acceptance range. (Table No. 4) . Table 3 : Evaluation data of precision study Ruggedness: Ruggedness of the method was determined by carrying out the analysis by two different analysts and the respective absorbance was noted. The result was indicated by % RSD.
RESULTS AND DISCUSSION
The developed method was found to be precise as the %RSD values for intra-day and inter-day were found to be less than 1%. Good recoveries (98.74% to 99.23%) of the drug were obtained at each added concentration, which indicates that the method was accurate. The method was also found to be robust and rugged as indicated by the %RSD values which are less than 1%.
CONCLUSION
The present analytical method was validated as per ICH guideline and it meets to specific acceptance criteria. It is concluded that the analytical method was specific, precise, linear, accurate, robust and having stability indicating characteristics. The present analytical method can be used for its intended purpose. 
